Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Accumulated Expenses (2021 - 2025)

Historic Accumulated Expenses for Tenon Medical (TNON) over the last 5 years, with Q3 2025 value amounting to $1.5 million.

  • Tenon Medical's Accumulated Expenses rose 6674.01% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 6674.01%. This contributed to the annual value of $910000.0 for FY2024, which is 1262.38% up from last year.
  • Per Tenon Medical's latest filing, its Accumulated Expenses stood at $1.5 million for Q3 2025, which was up 6674.01% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Tenon Medical's Accumulated Expenses peaked at $1.7 million during Q2 2022, and registered a low of $530000.0 during Q1 2023.
  • In the last 5 years, Tenon Medical's Accumulated Expenses had a median value of $921500.0 in 2024 and averaged $955250.0.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 4536.08% in 2023, then surged by 7754.72% in 2024.
  • Quarter analysis of 5 years shows Tenon Medical's Accumulated Expenses stood at $1.1 million in 2021, then plummeted by 33.24% to $717000.0 in 2022, then increased by 12.69% to $808000.0 in 2023, then grew by 12.62% to $910000.0 in 2024, then surged by 66.37% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $1.1 million for Q2 2025, and $911000.0 during Q1 2025.